Literature DB >> 22615710

A case of clear cell adenocarcinoma arising from the urethral diverticulum: Utility of urinary cytology and immunohistochemistry.

Shin-Ichi Nakatsuka1, Isao Taguchi, Tadasuke Nagatomo, Michiaki Yamane, Kenji Sugio, Ryuichi Yoshino, Kazuko Oku, Teruaki Nagano, Hayato Kimura, Kazuya Nakajo, Gaku Kawabata.   

Abstract

Carcinomas rarely arise from the urethral diverticulum. In this report, we present a case of clear cell adenocarcinoma arising from the urethral diverticulum. A 42-year-old woman complained of bloody discharge and lower back pain. Imaging studies showed a tumor involving the region surrounding the urethra and cystourethroscopy showed papillary and villous tumors in the urethral diverticula. Cytology of the urine sediment showed papillary or spherical clusters of atypical cells, some of which had clear abundant cytoplasm and formed mirror ball-like clusters, suggesting adenocarcinoma. Although histological diagnosis was indeterminate by biopsy and transurethral resection (TUR) because of absence of stromal invasion, surgically resected specimen via cysturethrectomy revealed that the tumor was clear cell carcinoma. Urinary cytological findings and immunohistochemical analysis for CD15, Ki-67, and p53 might be useful for accurate diagnosis of clear cell adenocarcinoma that arises from the urethral diverticulum when sufficient materials are not available by biopsy and TUR.

Entities:  

Keywords:  Clear cell adenocarcinoma; Ki-67; nephrogenic adenoma; p53; urethral diverticulum

Year:  2012        PMID: 22615710      PMCID: PMC3352587          DOI: 10.4103/1742-6413.95528

Source DB:  PubMed          Journal:  Cytojournal        ISSN: 1742-6413            Impact factor:   2.091


INTRODUCTION

Urethral carcinoma is a relatively rare tumor, which predominantly affects females. In very rare cases, carcinomas arise from the urethral diverticulum,[1] and only approximately 100 cases of urethral diverticulum-associated carcinomas have been reported so far.[2] Most of the urethral diverticulum-associated carcinomas are adenocarcinomas, whereas more than half of all urethral carcinomas are squamous cell carcinomas.[34] Some case reports have shown that clear cell adenocarcinoma (CCA) arises from the female urethral diverticulum.[5-9] CCA is typically an invasive tumor, but can sometimes show minimally invasive papillary growth without any solid nests of tumor cells in the limited amount of biopsied samples and transurethral resection (TUR). In such cases, histological differentiation between CCA and nephrogenic adenoma is extremely difficult.[10] In this report, we present a case of CCA arising from the urethral diverticulum, which showed nephrogenic adenoma-like histology in the biopsy and TUR. The cytological and immunohistochemical findings were informative for the accurate histological diagnosis of this tumor.

CASE REPORT

Clinical features

A 42-year-old woman presented with a 3-month history of bloody discharge from the urethra and lower back pain. Physical examination performed showed no remarkable changes on admission. She did not show urinary dysfunction. Laboratory data of the blood were within normal limits. Serum levels of tumor markers were not evaluated. Cytological examination of the urine sediment was highly suggestive of adenocarcinoma. Computed tomography (CT) and magnetic resonance imaging (MRI) showed a tumor (diameter, 47 mm), which involved the urethra entirely [Figure 1]. There were no remarkable changes in the gynecological system and no swelling was observed in the intra-abdominal and intrapelvic lymph nodes. Cystourethroscopy showed two diverticula fenestrated in the urethral wall. Whitish papillary and villous lesions were observed in both diverticula [Figure 2]. Specimens of biopsy and TUR histologically suggested CCA, but were indeterminate for malignancy. The patient underwent total cystourethrectomy and partial resection of the vaginal wall. Grossly, the tumor extended around the entire urethra and anterior vaginal wall. Final diagnosis of the resected tumor was CCA stage III pT3N0M0.
Figure 1

Magnetic resonance images of the tumor. The horizontal plane of the T1-weighted image shows that the tumor involves the region surrounding the urethra

Figure 2

Cystourethroscopic findings of the urethral lesion. The diverticulum made an orifice into the lumen of the ur ethra and a whitish papillary and villous tumor appeared from the orifice of the diverticulum

Magnetic resonance images of the tumor. The horizontal plane of the T1-weighted image shows that the tumor involves the region surrounding the urethra Cystourethroscopic findings of the urethral lesion. The diverticulum made an orifice into the lumen of the ur ethra and a whitish papillary and villous tumor appeared from the orifice of the diverticulum

Cytopathological features

The Papanicolaou-stained specimens showed a small number of papillary or spherical clusters of atypical cells with many benign urothelial cells and squamous cells in the background [Figure 3a and b]. A few neutrophils and lymphocytes were seen, but no necrotic debris was seen. The nuclei of the atypical cells showed an increase in the chromatin content with fine to granular pattern and irregular contours [Figure 3c]; the nucleoli were prominent. Most of the atypical cells had a moderate amount of cytoplasm that was lightly stained light green; however, some atypical cells showed clear, abundant cytoplasm that formed spherical clusters resembling “mirror balls” [Figure 3b]. These findings suggested a malignant tumor of the urinary system and favored adenocarcinoma.
Figure 3

Cytological findings of the urine sediments. Papanicolaou staining, a) A papillary cluster of tumor cells. The tumor cells with hyperchromatism are piled up irregularly (1000×), b) A spherical cluster of clear cells (400×), c) Nuclei of the tumor cells showing fine to granular chromatin and prominent nucleoli (1000×)

Cytological findings of the urine sediments. Papanicolaou staining, a) A papillary cluster of tumor cells. The tumor cells with hyperchromatism are piled up irregularly (1000×), b) A spherical cluster of clear cells (400×), c) Nuclei of the tumor cells showing fine to granular chromatin and prominent nucleoli (1000×)

Histopathologic features

The biopsy and TUR samples showed that the tumor comprised papillo-tubular lesions [Figure 4a]. The epithelial cells covering the tumor were cuboidal and single layered, and some of these cells showed a “hobnail pattern.” Most of the cells had eosinophilic cytoplasm, except for a few that had clear cytoplasm. The cells with a clear cytoplasm were positive for periodic acid-Schiff reaction. The epithelial cells showed relatively mild cytological atypia and did not invade the stroma. Mitotic figures were observed at a frequency of 10/10 high-power fields. Necrotic debris was frequently observed in the lumen of the tubular structures. In immunohistochemistry, the tumor cells were positive for cytokeratin (CK) 7 [SP52, ready-to-use (RTU) prediluted, Ventana Medical Systems, Tucson, AZ, USA], epithelial membrane antigen (EMA) (E29, RTU prediluted, Nichirei Bioscience, Tokyo, Japan), and carbohydrate antigen (CA) 125 (M11, 1:25, Dako, Glostrup, Denmark), and were also focally positive for CD15 (80H5, RTU prediluted, Immunotech, Marseille, France) [Figure 4b]. The tumor cells were negative for CK 5/6 (D5/16 B4, 1:50, Dako), CK 20 (SP33, RTU prediluted, Ventana Medical Systems), carcinoembryonic antigen (12-140-10, RTU prediluted, Leica Microsystems, Milton Keynes, UK), thrombomodulin (1009, 1:50, Dako), uroplakin III (AU1, RTU prediluted, Nichirei Bioscience), prostate-specific antigen (polyclonal, Dako), calretinin (5A5, RTU prediluted, Leica Microsystems), estrogen receptor (6F11, 1:50, Leica Microsystems), and progesterone receptor (312, 1:50, Leica Microsystems). Histological findings suggested diagnosis of CCA, although definite diagnosis of the malignancy could not be elicited because of absence of stromal invasion in both biopsy and TUR samples. In the surgically resected specimens, clear atypical cells with papillo-tubular structure invaded almost all layers of the urethra and vaginal muscular layer. The final definite diagnosis was CCA.
Figure 4

Histological and immunohistochemical findings, a) A biopsied specimen showing a papillary lesion covered with cuboidal cells. A hobnail pattern configuration was observed without any stromal invasion. A few clear cells were also observed (inset) (H and E 200×), b) The tumor cells were positive for CD15 (H and E 200×), c) The Ki-67 labeling index was approximately 20% (H and E 100×)

The Ki-67 labeling index of these tumor cells was approximately 20% [Figure 4c] and approximately 5% of the tumor cells showed strong p53 positivity in the nucleus. Histological and immunohistochemical findings, a) A biopsied specimen showing a papillary lesion covered with cuboidal cells. A hobnail pattern configuration was observed without any stromal invasion. A few clear cells were also observed (inset) (H and E 200×), b) The tumor cells were positive for CD15 (H and E 200×), c) The Ki-67 labeling index was approximately 20% (H and E 100×)

DISCUSSION

Carcinomas rarely arise from the urethral diverticulum. Hamilton and Leach were the first to describe the carcinomas arising from the urethral diverticulum.[1] Approximately 100 cases of urethral diverticulum-associated carcinomas have been reported so far.[2] Although squamous cell carcinomas represent the most common histology of urethral carcinomas, adenocarcinomas most commonly develop from the urethral diverticulum. According to the data presented by Clayton et al. and Evans et al., 46-56% of the urethral diverticulum-associated carcinomas are adenocarcinomas and only 15-18% are squamous cell carcinoma.[34] CCAs are especially associated with the urethral diverticulum, and 56% of the urethral CCAs are associated with the urethral diverticulum.[6] CCA has also been called mesonephric adenocarcinoma, but the hypothesis that CCAs originate from the mesonephric tissue has now been abandoned. The histogenesis of the urethral diverticulum-associated CCAs remains unclear. Based on the fact that more than half of the bladder CCAs contain focal components of urothelial carcinoma or remnants of benign urothelium within the tumor,[911] most CCAs are supposed to be derived from the peculiar glandular differentiation of urothelial neoplasms.[11] The present case showed a transition between CCA and benign urothelium of the diverticulum, which was consistent with urothelial origin of the tumor. Washino et al. described that urine cytology is relatively sensitive for the detection of atypical cells with a positive rate of 85%[8] however, definitive identification of histological subtype based on the cytological findings is often difficult. In most of the reported cases, diagnosis based on urine cytology was urothelial carcinoma. In the present case, urine cytology could not determine the histological subtype of the tumor; however, in the retrospective review of the specimens, the spherical clusters of atypical cells with clear, abundant cytoplasm were suggestive of CCA. Histological diagnosis of CCA is usually not difficult if stromal invasion is observed. However, if the tumor is minimally invasive and present in limited specimens, it is very difficult to distinguish between CCA and nephrogenic adenoma. Herawi et al. described seven cases with minimally invasive CCAs histologically similar to nephrogenic adenoma.[10] They reported that nuclear atypia, increased mitotic figures, intraluminal necrosis, focal clear cells, focal solid areas, and elevated Ki-67 and p53 indices were the key features for distinguishing between nephrogenic adenoma-like CCA and nephrogenic adenoma. Other differential diagnoses of CCA are urothelial carcinoma, adenocarcinoma not otherwise specified (adenocarcinoma NOS), and metastatic adenocarcinoma. A systematic workup of the primary tumor site and close histological examination for the identification of the hobnail pattern are essential for differentiating CCA from other tumors. Immunohistochemistry for CD15 is also useful for the differentiation of CCA from other carcinomas. In this report, we presented a rare case of CCA arising from the urethral diverticulum. In the presence of a urethral diverticulum, clear cell tumor cells clustering like mirror balls in urine cytology are suggestive of CCA and, because these tumors have a propensity to arise in urethral diverticula, the presence of malignant clear cells in urine sample should raise the possibility of origin from urethral diverticulum. When CCA gives a nephrogenic adenoma-like appearance in limited histologic specimens, cytologic findings in urine sediment and positivity for p53 and Ki-67 immunohistochemical stains might be helpful in making an accurate diagnosis.

COMPETING INTERESTS STATEMENT BY ALL AUTHORS

The authors declare that they have no competing interests.

AUTHORSHIP STATEMENT BY ALL AUTHORS

All authors of this article declare that we qualify for authorship as defined by ICMJE. All authors are responsible for the conception of this study, participated in its design and coordination, and helped to draft the manuscript. All authors read and approved the final manuscript.

ETHICS STATEMENT BY ALL AUTHORS

As this is a case without patient identifiers, approval from the Institutional Review Board (IRB) is not required at our institution.

EDITORIAL / PEER-REVIEW STATEMENT

To ensure the integrity and highest quality of CytoJournal publications, the review process of this manuscript was conducted under a double blind model (authors are blinded for reviewers and vice versa) through automatic online system.
  11 in total

Review 1.  Urethral diverticular carcinoma.

Authors:  M Clayton; P Siami; P Guinan
Journal:  Cancer       Date:  1992-08-01       Impact factor: 6.860

2.  Adenocarcinoma arising in a diverticulum of the female urethra.

Authors:  J D HAMILTON; W B LEACH
Journal:  AMA Arch Pathol       Date:  1951-01

3.  Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems.

Authors:  Esther Oliva; Mahul B Amin; Rafael Jimenez; Robert H Young
Journal:  Am J Surg Pathol       Date:  2002-02       Impact factor: 6.394

4.  Clear cell adenocarcinoma in a female urethral diverticulum.

Authors:  A Collado; F Algaba; J Caparrós; J Alberola; M Montlleó; P Arañó; H Villavicencio
Journal:  Scand J Urol Nephrol       Date:  2000-04

5.  Adenocarcinoma of a female urethral diverticulum: case report and review of the literature.

Authors:  K J Evans; M P McCarthy; J P Sands
Journal:  J Urol       Date:  1981-07       Impact factor: 7.450

6.  Laparoscopic radical cystourethrectomy in a patient with adenocarcinoma of the female urethral diverticulum.

Authors:  Hong Koo Ha; Wan Lee; Sang Don Lee; Jeong Zoo Lee; Moon Kee Chung
Journal:  Korean J Urol       Date:  2010-02-18

7.  [A case of adenocarcinoma in female urethral diverticulum].

Authors:  Satoshi Washino; Fumihiko Terauchi; Atsushi Matsuzaki; Yutaka Kobayashi; Shigeki Yamada
Journal:  Hinyokika Kiyo       Date:  2007-08

Review 8.  Clear cell adenocarcinoma arising from a urethral diverticulum.

Authors:  R M Seballos; R R Rich
Journal:  J Urol       Date:  1995-06       Impact factor: 7.450

9.  Histogenesis of clear cell adenocarcinoma in the urinary tract: evidence of urothelial origin.

Authors:  Ming-Tse Sung; Shaobo Zhang; Gregory T MacLennan; Antonio Lopez-Beltran; Rodolfo Montironi; Mingsheng Wang; Puay-Hoon Tan; Liang Cheng
Journal:  Clin Cancer Res       Date:  2008-04-01       Impact factor: 12.531

10.  Clear cell adenocarcinoma of the bladder and urethra: cases diffusely mimicking nephrogenic adenoma.

Authors:  Mehsati Herawi; Peter A Drew; Chin-Chen Pan; Jonathan I Epstein
Journal:  Hum Pathol       Date:  2010-01-08       Impact factor: 3.466

View more
  7 in total

1.  The epidemiology and role of surgery in the treatment of urethral clear cell carcinoma.

Authors:  Mausam Patel; Jay Im; Austin Ivy; Sanjay Maraboyina; Thomas Kim
Journal:  Int Urol Nephrol       Date:  2019-09-25       Impact factor: 2.370

2.  Primary urethral clear-cell adenocarcinoma: comprehensive analysis by surgical pathology, cytopathology, and next-generation sequencing.

Authors:  Rohit Mehra; Pankaj Vats; Shanker Kalyana-Sundaram; Aaron M Udager; Michael Roh; Ajjai Alva; Jincheng Pan; Robert J Lonigro; Javed Siddiqui; Alon Weizer; Cheryl Lee; Xuhong Cao; Yi-Mi Wu; Dan R Robinson; Saravana M Dhanasekaran; Arul M Chinnaiyan
Journal:  Am J Pathol       Date:  2014-01-03       Impact factor: 4.307

3.  Unusual Features of Clear Cell Adenocarcinoma of the Female Urethra: A Case Report and Literature Review.

Authors:  Jianfeng Zeng; Shanyun Wang; Liang Zhong; Zhifeng Huang; Ye Zeng; Song Wu; Dongxiang Zheng; Weiwei Zou; Haibiao Lai
Journal:  J Clin Med Res       Date:  2018-06-27

4.  Thank you CytoJournal reviewers for your 2012 and 2013 services!

Authors:  Vinod B Shidham; Richard M Demay
Journal:  Cytojournal       Date:  2014-03-20       Impact factor: 2.091

Review 5.  Clear cell adenocarcinoma of the urethra: review of the literature.

Authors:  Anthony Kodzo-Grey Venyo
Journal:  Int J Surg Oncol       Date:  2015-01-20

Review 6.  Urethral diverticulum carcinoma in females-a case series and review of the English and Japanese literature.

Authors:  Eabhann O'Connor; Domniki Iatropoulou; Sho Hashimoto; Satoru Takahashi; Daniel Heffernan Ho; Tamsin Greenwell
Journal:  Transl Androl Urol       Date:  2018-08

7.  Announcement of first time Cytojournal impact factor for 2012 coincides with Cytojournal decade celebration (2004-2013).

Authors:  Vinod B Shidham; Richard M Demay
Journal:  Cytojournal       Date:  2013-08-30       Impact factor: 2.091

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.